HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Help viewing high resolution images Return to article

FIGURE 5.  Therapeutic efficacy of ⁹⁰Y-labeled peptide pretargeted with an anti-MUC1 DNL bs-mAb. Nude mice bearing 0.5 cm³ CaPan1 human pancreatic cancer subcutaneous xenografts were untreated (A; n = 10 mice) or were treated with 18.5 MBq (0.5 mCi) of a pretargeted ⁹⁰Y-labeled hapten-peptide (B; n = 10 mice).

Return to article